Western pharmaceutical companies linked to corrupt Russian middlemen, report finds
An ICIJ investigation reveals Western drugmakers paid millions to corrupt Russian distributors to secure government cancer drug contracts, inflating patient costs.
Leaked whistleblower documents reveal that major Western pharmaceutical firms have paid millions of dollars to Russian distribution partners linked to corruption allegations. According to an investigation by the International Consortium of Investigative Journalists, companies including Merck utilized politically connected Russian middlemen to secure lucrative government contracts for critical treatments, such as the cancer drug Keytruda.
The reports suggest these arrangements involved substantial financial bonuses for distributors, which ultimately drove up drug prices for Russian patients needing lifesaving therapies. Despite international sanctions and ethical concerns surrounding business dealings in Russia, several global drugmakers continued relying on local intermediaries with close ties to high-ranking officials to maintain market access.
Sources: ICIJ